Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
The Wealth Company Mid cap Fund (G)
[Equity: Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 04-Aug-26
Corpus(Cr.) 172.00 Latest NAV 9.1574 As on 29-10-2026
Equity(%) 89.43 52 Week High 10.0331
Debt(%) 10.57 52 Week Low 8.8482
Others(%) 0.00 Exit Load 1% for redemption within 180 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Midcap 150 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Aparna Shanker
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. There is no assurance that the investment objective of the Scheme will be achieved.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 30.31%
Top 10 Holdings 48.46%
Top 25 Holdings 80.34%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 12.89
Consumer Durables 12.78
SERVICES 12.64
Automobile 11.21
Cash 10.57
Banking & Financial 7.16
Electricals 6.85
Miscellaneous 6.47
Retail 6.21
Healthcare 2.85
FMCG 2.61
Chemicals 2.22
Transportation 1.66
Minerals & Mining 1.33
Industrial Products 1.05
Metals 0.99
Finance & Investments 0.42
Technology 0.09
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.07
PE Ratio 33.10
 
Top 25 Holdings
Holdings Net Asset(%)
The Clearing Corporation of India Ltd. 01-OCT-2026 10.33
Indian Hotels Co. Ltd 6.02
GE Vernova T&D India Limited 4.88
Dixon Technologies (India) Limited 4.79
Dr. Reddys Laboratories Ltd. 4.29
HDFC Bank Ltd. 4.11
Balkrishna Industries Ltd. 3.68
ITC Hotels Limited 3.64
SWIGGY LIMITED 3.63
ICICI Prudential Life Insurance Company Limited 3.09
360 ONE WAM LIMITED 2.69
Prestige Estates Projects Limited 2.58
M.R.F. Ltd. 2.55
Voltas Ltd. 2.48
Crompton Greaves Consumer Electricals Limited 2.30
Endurance Technologies Limited 2.16
Biocon Ltd. 2.15
Glenmark Pharmaceuticals ltd 2.03
BASF India Ltd 2.00
Thermax Ltd. 1.97
Tube Investments of India Ltd 1.94
Fortis Healthcare Ltd 1.79
NIVA BUPA HEALTH INSURANCE COMPANY LIMITED 1.79
Amber Enterprises India Limited 1.74
ALEMBIC PHARMACEUTICALS LIMITED 1.71

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.68% -8.43% 0.00% 0.00%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Midcap 150 TRI]
-2.74% -7.99% -4.00% -3.65%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
0.00% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
1.51% 14.17% 14.04% 15.82%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection